CUI Xin,LI Qiu-hong,ZHANG Xiao-xue.Effects of miR-375 knockdown on the proliferation and apoptosis of trophoblast cells in a preeclampsia model and its mechanism[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(11):980-984.
CUI Xin,LI Qiu-hong,ZHANG Xiao-xue.Effects of miR-375 knockdown on the proliferation and apoptosis of trophoblast cells in a preeclampsia model and its mechanism[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(11):980-984. DOI: 10.11659/jjssx.02E024023.
Effects of miR-375 knockdown on the proliferation and apoptosis of trophoblast cells in a preeclampsia model and its mechanism
To investigate the effects of miR-375 knockdown on the proliferation and apoptosis of trophoblast cells in preeclampsia (PE) model and its mechanism.
Methods
2
Human chorionic trophoblast cell line HTR-8/Svneo was randomly divided into the normoxic control group, the PE model group, the miR-NC group, and the miR-375 inhibitor group. Among them, cells in the miR-NC group and miR-375 inhibitor group were transfected with miR-NC and miR-375 inhibitor, respectively;cells in the normoxic control group were cultured in a normoxic enviroment,and cells in the remaining three groups were cultured under hypoxic conditions to establish the PE trophoblast cell model. The expression of miR-375 was detected by RT-PCR, the proliferation of cells was detected by EdU fluorescence staining and CCK-8 assay, the apoptosis of cells was detected by flow cytometry, and the expression of YAP1 protein and apoptosis-related proteins (Bcl-2, caspase-3, and Bax proteins) were detected by Western blot. The target regulation relationship between miR-375 and YAP1 was detected by dual luciferase reporter gene assay.
Results
2
Compared with the normoxic control group, the PE model group showed an increase in the expression of miR-375 (
P
<
0.05), a decrease in the proportion of EdU-positive cells (
P<
0.05), a decline in the cell proliferation ability (
P
<
0.05), increases in the apoptosis rate (
P
<
0.05) and the expression levels of Bax and caspase-3 proteins (
P
<
0.05), and a decrease in the expression levels of YAP1 and Bcl-2 proteins (
P
<
0.05). There was no significant difference in the above indicators between the PE model group and the miR-NC group (
P
>
0.05). Compared with the miR-NC group, the miR-375 inhibitor group showed a lower expression of miR-375 (
P
<
0.05), an increased percentage of EdU-positive cells (
P
<
0.05), an enhanced cell proliferation ability (
P
<
0.05), a lower apoptosis rate (
P
<
0.05), and a lower expression of Bax and caspase-3 proteins (
P
<
0.05), while with a higher expression of YAP1 and Bcl-2 proteins (
P
<
0.05). The dual luciferase reporter gene assay showed that miR-375 had a targeted regulatory effect on YAP1 (
P
<
0.05).
Conclusion
2
Knocking down miR-375 can promote the proliferation and inhibit the apoptosis of PE trophoblast cells, and its mechanism may be related to its targeted regulation of YAP1 gene.
Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia[J]. Lancet, 2016, 387(10022):999-1011. doi: 10.1016/S0140-6736(15)00070-7http://dx.doi.org/10.1016/S0140-6736(15)00070-7.
Jung E, Romero R, Yeo L, et al. The etiology of preeclampsia[J]. Am J Obstet Gynecol, 2022, 226(2S):S844-S866. doi:10.1016/j.ajog.2021.11.1356http://dx.doi.org/10.1016/j.ajog.2021.11.1356.
Bakrania BA, Spradley FT, Drummond HA, et al. Preeclampsia: linking placental ischemia with maternal endothelial and vascular dysfunction[J]. Compr Physiol, 2020, 11(1):1315-1349.doi:10.1002/cphy.c200008http://dx.doi.org/10.1002/cphy.c200008.
Liu S, Xie X, Lei H, et al. Identification of key circRNAs/lncRNAs/miRNAs/mRNAs and pathways in preeclampsia using bioinformatics analysis[J]. Med Sci Monit, 2019, 25:1679-1693.doi:10.12659/MSM.912801http://dx.doi.org/10.12659/MSM.912801.
Hromadnikova I,Kotlabova K,Dvorakova L, et al.Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications[J]. Int J Cardiol, 2019, 291:158-167.doi:10.1016/j.ijcard.2019.05.036http://dx.doi.org/10.1016/j.ijcard.2019.05.036.
Liu Y, Wang Q, Wen J, et al. MiR-375: a novel multifunctional regulator[J].Life Sci,2021,275(1):119323.doi:10.1016/j.lfs.2021.119323http://dx.doi.org/10.1016/j.lfs.2021.119323.
Akgör U, Ayaz L, Çayan F. Expression levels of maternal plasma microRNAs in preeclamptic pregnancies[J]. J Obstet Gynaecol, 2021, 41(6):910-914. doi:10.1080/01443615.2020.1820465http://dx.doi.org/10.1080/01443615.2020.1820465.
Ren Y, Xu Y, Wang Y, et al. Regulation of miR-375 and Sonic hedgehog on vascular endothelial growth factor in preeclampsia rats and its effect on trophoblastcells[J]. Biosci Rep, 2020, 15(1):BSR20200613. doi:10.1042/BSR20200613http://dx.doi.org/10.1042/BSR20200613.
Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia[J]. Med Princ Pract, 2013, 22(Suppl 1):8-19.doi:10.1159/000354200http://dx.doi.org/10.1159/000354200.
Warrington JP, George EM, Palei AC, et al.Recent advances in the understanding of the pathophysiology of preeclampsia[J].Hypertension, 2013, 62(4):666-673. doi:10.1161/HYPERTENSIONAHA.113.00588http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.00588.
Betoni JS,Derr K,Pahl MC,et al.MicroRNA analysis in placentas from patients with preeclampsia: comparison of new and published results[J].Hypertens Pregnancy,2013,32(4):321-339.doi:10.3109/10641955.2013.807819http://dx.doi.org/10.3109/10641955.2013.807819.
Mo W, Jin J, Wang X, et al. MicroRNA-206 contributes to the progression of preeclampsia by suppressing the viability and mobility of trophocytes via the inhibition of AGTR1[J]. Physiol Res, 2023, 72(5):597-606. doi:10.33549/physiolres.935131http://dx.doi.org/10.33549/physiolres.935131.
Gu Y, Song N, Gu WW, et al. Down-regulation of miR-486-5p expression inhibits the proliferation and invasion of human extravillous trophoblasts, and decreased peripheral plasma miR-486-5p level is associated with human early pregnancy loss[J]. Acta Biochim Biophys Sin (Shanghai), 2023, 55(11):1847-1850. doi:10.3724/abbs.2023239http://dx.doi.org/10.3724/abbs.2023239.
Ko S, Kim M, Molina L, et al. YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma[J]. Adv Cancer Res, 2022,156(1):283-317. doi: 10.1016/bs.acr.2022.02.003http://dx.doi.org/10.1016/bs.acr.2022.02.003.
Liu R, Wei C, Ma Q, et al. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population[J]. Pregnancy Hypertens, 2020, 19(1):1-10. doi:10.1016/j.preghy.2019.11.002http://dx.doi.org/10.1016/j.preghy.2019.11.002.
Xu B, Geng X, Liu X, et al. Long non-coding RNA FAM99A modulated YAP1 to affect trophoblast cell behaviors in preeclampsia by sponging miR-134-5p[J]. Braz J Med Biol Res, 2020, 53(12):e9732. doi:10.1590/1414-431X20209732http://dx.doi.org/10.1590/1414-431X20209732.
Hu Y, Ma Y, Luo G, et al. Effect of miR-375 regulates YAP1 on the invasion,apoptosis,and epithelial-mesenchymal transition of cervical cancer HeLa cells[J]. Evid Based Complement Alternat Med, 2021, 2021(1):3088723. doi:10.1155/2021/3088723http://dx.doi.org/10.1155/2021/3088723.
Wang X, Ou H, Zhou L, et al. Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis[J]. Exp Ther Med, 2021, 22(1):754. doi:10.3892/etm.2021.10186http://dx.doi.org/10.3892/etm.2021.10186.
Effect of circDNMT1 regulating miR-377-3p/PUM1 axis on proliferation,apoptosis and epithelial-mesenchymal transition of triple-negative breast cancer cells
lncRNA NEAT1 promoting the proliferation and apoptosis escape of laryngeal papilloma cells by activating BZW2 through the inhibition of miR-let-7a
Mechanism of lncRNA MIR4435-2HG targeting miR-376a-3p to regulate the biological behavior of cholangiocarcinoma cells
Effects and molecular mechanisms of Epac1 on pituitary adenoma cell proliferation and cell cycle
Expression and biological role of DCST1-AS1 in non-small cell lung cancer
Related Author
LIN Yao-ting
LU Hong-quan
ZHENG Mei-ling
LIN Ming-li
ZHANG Bo
WANG Song
Ayiheng· Qukuerhan
YU Zi-dan
Related Institution
Department of General Surgery,Danzhou People's Hospital
Department of Medical Oncology,Hainan Western Central Hospital
Department of Laboratory, Danzhou People's Hospital
Department of Otolaryngology,First Affiliated Hospital of Xinjiang Medical University
Rehabilitation Center, Huizhou Third People's Hospital